Table 3.
Summary of tandutinib dose escalation
| Dose level, mg twice daily | No. of patients | No. of patients with DLTs | No. of patients with FLT3-ITD |
|---|---|---|---|
| 50 | 6 | 0 | 0 |
| 100 | 3 | 0 | 0 |
| 150 | 6 | 1 | 1 |
| 200 | 3 | 0 | 0 |
| 250 | 3 | 0 | 0 |
| 300 | 6 | 1 | 1 |
| 400 | 4 | 0 | 1 |
| 525 | 6 | 1 | 3 |
| 700 | 3 | 3 | 2 |
| Total | 40 | 6 | 8 |
Summary of tandutinib dose escalation
| Dose level, mg twice daily | No. of patients | No. of patients with DLTs | No. of patients with FLT3-ITD |
|---|---|---|---|
| 50 | 6 | 0 | 0 |
| 100 | 3 | 0 | 0 |
| 150 | 6 | 1 | 1 |
| 200 | 3 | 0 | 0 |
| 250 | 3 | 0 | 0 |
| 300 | 6 | 1 | 1 |
| 400 | 4 | 0 | 1 |
| 525 | 6 | 1 | 3 |
| 700 | 3 | 3 | 2 |
| Total | 40 | 6 | 8 |